OpenClinical trial: Required
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
National Institutes of Health (NIH) · NIH Institute/Center · PAR-24-295
Source: Grants.gov · View original posting ↗
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Amount not listed
- DeadlineFinal application due date.
- Dec 3, 2026
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- —
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Standard NIH dates
- Open dateWhen applications open (or opened).
- Oct 15, 2024
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- —
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Required
Foreign entities
Research areas
Clinical trials
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.